Robert Stannert

Dr. Robert Stannert

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
GGGabriel Alejandro Garibaldi
Gabriel Alejandro Garibaldi
JAJimena Berenice Alegria
Jimena Berenice Alegria
ASAnita Shayan
Anita Shayan
RSRobert Stannert
Robert Stannert
Nehal Abu-LailNehal Abu-Lail
Nehal Abu-Lail
GSGongchen Sun
Gongchen Sun
Sorting and isolating specific cells from heterogeneous populations are crucial for many biomedical applications, including drug discovery and medical diagnostics. Conventional methods such as Fluorescent Activated Cell Sorting (FACS) and Magnetic Activated Cell Sorting (MACS) face limitations in throughput, cost, and the ability to separate subtly different cells. Cell partitioning in Aqueous Two-Phase Systems (ATPSs) offers a biocompatible and cost-effective alternative, particularly when combined with continuous-flow microfluidics. However, it remains challenging to rationally design microfluidic ATPS devices and operation to separate cells with similar origin but different phenotypes. In this paper, using a model ATPS, polyethylene glycol (PEG)—Dextran (Dex) system, and model cells, human chondrocytes (hChs), and carboxylated polystyrene (PS) microparticles, we systematically characterized the material properties affecting cell partitioning in ATPSs, such as surface energies of the solutions and cells and solution viscosities. We developed an energy balance approach between interfacial energy and viscous dissipation to estimate the interface translocation dynamic of cells partitioning into the preferred phase. Combining the experimental measurement and the energy balance model, our calculation reveals that the time required for complete cell partitioning at the ATPS interface can be exploited in microfluidic ATPS devices to separate hChs with different phenotypes (healthy and diseased). We expect our dynamic energy approach to provide a basis and a design strategy for optimizing microfluidic ATPS devices to achieve the efficient separation of phenotypically similar cell populations and further expand the potential of microfluidic cell separation.

11 June 2026 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Open access
RSRobert Stannert
Robert Stannert
LALindsey Attebery
Lindsey Attebery
ARAbraham Rodriguez
Abraham Rodriguez
Osteoarthritis (OA) is a common degenerative joint disease characterized by the progressive degeneration of articular cartilage (AC), resulting in pain, stiffness, and reduced joint function. Despite its widespread prevalence, effective treatments for OA remain elusive, partly due to challenges in accurately modeling the disease. In the present study, adhesion energy, collagen (COL), and total glycosaminoglycans (GAG), the main extracellular matrix (ECM) components of AC, and their potential correlations were evaluated in human chondrocytes derived from both healthy and OA male donors. A model surface of silicon nitride was used to investigate adhesion energy using atomic force microscopy (AFM), while colorimetric assays were applied to quantify COL and GAG at five different time points during monoculture (days 0, 1, 7, 14, and 21). Our results indicate significant heterogeneity in adhesion energies at both donor and phenotype levels. Chondrocytes isolated from healthy donors consistently display higher adhesion energies, along with greater heterogeneity, compared to those derived from OA donors. These differences in adhesion energy and heterogeneity can be attributed to greater diversity and density of cellular surface molecules in cells from healthy donors. In contrast, total GAG and COL levels were significantly elevated in OA chondrocytes compared to those in healthy chondrocytes. Moreover, the study found a positive correlation between adhesion energy and GAG production in OA-derived chondrocytes, but no significant correlations with DNA or COL levels. No correlation was observed between adhesion energy and GAG, DNA, or COL levels in healthy cells. In conclusion, these findings highlight the importance of considering individual donor characteristics when developing OA disease models, therapeutics, or engineered tissues.